Dr Ali is leader of the Systems Cancer Pathology group based at CRUK Cambridge Institute, University of Cambridge and an Honorary Consultant Pathologist at Addenbrookes hospital. His group uses imaging mass cytometry to understand the spatial dynamics of breast cancer through disease progression and treatment, in order to identify adaptations and biomarkers associated with relapse and response.